Literature DB >> 8270619

The expression of basic fibroblast growth factor and its receptor in cell lines derived from normal human mammary gland and a benign mammary lesion.

Y Ke1, D G Fernig, M C Wilkinson, J H Winstanley, J A Smith, P S Rudland, R Barraclough.   

Abstract

mRNA for basic Fibroblast Growth Factor (bFGF) was expressed in a series of SV40-transformed human mammary cell lines as molecules of 7.1, 3.6, 2.0 and 1.2 kb. This expression was much weaker in those lines of epithelial morphology than in myoepithelial-like cell lines derived from them. It was confirmed, using northern hybridization to single-stranded RNA probes, that the multiple mRNAs were transcribed from the coding strand for bFGF. bFGF activity was detected in extracts of the cells and the relative amounts of activity corresponded in general to the amounts of mRNA found. Similar results were obtained from spontaneously transformed cell lines derived from a human benign breast lesion. The presence of bFGF protein in the extracts was confirmed by western blotting, which showed a band of 18-19 kDa, migrating in the same position as authentic bFGF; in addition, the myoepithelial-like cells showed prominent bands of bFGF at 24 and 26 kDa. No FGF receptor was detectable by the binding of 125I-bFGF to the SV40-transformed cell lines or to the epithelial cell lines from the benign breast lesion, but both high- and low-affinity receptors were found on myoepithelial-like cells derived from the latter. The results indicate that differentiation to the human myoepithelial-like phenotype in culture is associated with the enhanced expression of bFGF, and it is suggested that bFGF, immunocytochemically detected in the basement membrane of the human breast, may arise, at least in part, from the myoepithelial cells of the mammary parenchyma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270619     DOI: 10.1242/jcs.106.1.135

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  8 in total

1.  An in vitro model of epithelial cell growth stimulation in the rodent mammary gland.

Authors:  U K Ehmann; J T DeVries; M S C Chen; A A Adamos; R C Guzman; M B Omary
Journal:  Cell Prolif       Date:  2003-08       Impact factor: 6.831

2.  Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis.

Authors:  S W McLeskey; L Zhang; S Kharbanda; J Kurebayashi; M E Lippman; R B Dickson; F G Kern
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance.

Authors:  C Yiangou; J J Gomm; R C Coope; M Law; Y A Luqmani; S Shousha; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Expression of calcium-binding protein S100A2 in breast lesions.

Authors:  D Liu; P S Rudland; D R Sibson; A Platt-Higgins; R Barraclough
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

5.  FGF-2, TGFbeta-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study.

Authors:  Lucyene Miguita; Elizabeth Ferreira Martinez; Ney Soares de Araújo; Vera Cavalcanti de Araújo
Journal:  J Appl Oral Sci       Date:  2010 Jan-Feb       Impact factor: 2.698

6.  Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma.

Authors:  R Colomer; J Aparicio; S Montero; C Guzmán; L Larrodera; H Cortés-Funes
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease.

Authors:  S Y Anandappa; J H Winstanley; S Leinster; B Green; P S Rudland; R Barraclough
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

8.  Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells.

Authors:  D Liu; P S Rudland; D R Sibson; R Barraclough
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.